EMAIL THIS PAGE TO A FRIEND

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Prospectively planned analysis of data from a phase III study of liposomal muramyltripeptide phosphatidylethanolamine in the treatment of osteosarcoma.


PMID 16155031

Abstract

We're sorry this abstract is currently not available.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

SML0195
Mifamurtide, ≥98% (HPLC)
C59H109N6O19P